[Antioxidant action and sympatho-inhibitory effect of ARB].
Hitooks
Yoshitaka
Y
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences.
Sunagawa
Kenji
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008928:Mitochondria / Q000378:metabolism; D019255:NADPH Oxidases / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000502:physiology; D018384:Oxidative Stress / Q000187:drug effects*; D013481:Superoxides / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014969:Xanthine Oxidase / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000975:Antioxidants; D013481:Superoxides; D019001:Nitric Oxide Synthase; D014969:Xanthine Oxidase; D019255:NADPH Oxidases